In a clinical research of advanced gastric cancer (AGC), Sasaki et al. [14] treated 64 patients with nivolumab and observed that C-reactive protein (CRP) and absolute neutrophil count (ANC) levels were significantly increased only in patients with HPD. This evidence concerns the gene CRP and gastric cancer.